 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/04/2026 |
$27.77 |
$28.19 |
$27.65 |
$28.02 |
1.68M | | 09/08/2026 |
$27.63 |
$28.09 |
$27.10 |
$27.58 |
1.46M | | 09/09/2026 |
$27.44 |
$27.95 |
$27.40 |
$27.68 |
1.29M | | 09/10/2026 |
$27.63 |
$27.86 |
$27.36 |
$27.74 |
1.01M | | 09/11/2026 |
$27.98 |
$28.24 |
$27.74 |
$27.83 |
1.17M |
 |
| Acadia Pharmaceuticals Inc. is a biopharmaceutical company. Co. is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. | |
 |

Acadia Pharmaceuticals (ACAD) has the following price history information. Looking back at ACAD historical stock prices for the last five trading days, on September 04, 2026, ACAD opened at $27.77, traded as high as $28.19 and as low as $27.65, and closed at $28.02. Trading volume was a total of 1.68M shares. On September 08, 2026, ACAD opened at $27.63, traded as high as $28.09 and as low as $27.10, and closed at $27.58. Trading volume was a total of 1.46M shares. On September 09, 2026, ACAD opened at $27.44, traded as high as $27.95 and as low as $27.40, and closed at $27.68. Trading volume was a total of 1.29M shares. On September 10, 2026, ACAD opened at $27.63, traded as high as $27.86 and as low as $27.36, and closed at $27.74. Trading volume was a total of 1.01M shares. On September 11, 2026, ACAD opened at $27.98, traded as high as $28.24 and as low as $27.74, and closed at $27.83. Trading volume was a total of 1.17M shares.
ACAD Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acadia Pharmaceuticals shares, starting with a $10,000 purchase of ACAD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/14/2016 |
|
| End date: |
09/11/2026 |
|
| Start price/share: |
$33.41 |
|
| End price/share: |
$27.83 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-16.70% |
|
| Average Annual Total Return: |
-1.81% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$8,330.95 |
|
| Years: |
10.00 |
|
|
 |
| Date |
Close |
| 09/04/2026 | $28.02 | | 09/08/2026 | $27.58 | | 09/09/2026 | $27.68 | | 09/10/2026 | $27.74 | | 09/11/2026 | $27.83 |
|
 |